This review summarises three key presentations focused on HER2-mutated non-small cell lung cancer from the Advances in Lung Cancer Summit, an educational meeting developed and led by an independent steering committee. Speakers included Professor Wendy Cooper, Associate Professor Tim Clay and Associate Professor Malinda Itchins.
Please login below to download this issue (PDF)